Cart
sales@molnova.com
Methyl 2,5-dihydroxycinnamate
CAS No. 63177-57-1
Methyl 2,5-dihydroxycinnamate ( —— )
Catalog No. M27654 CAS No. 63177-57-1
Methyl 2,5-dihydroxycinnamate is an EGF receptor-associated tyrosine kinases inhibitor.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 50 | Get Quote |
|
| 10MG | 87 | Get Quote |
|
| 25MG | 177 | Get Quote |
|
| 50MG | 335 | Get Quote |
|
| 100MG | 500 | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameMethyl 2,5-dihydroxycinnamate
-
NoteResearch use only, not for human use.
-
Brief DescriptionMethyl 2,5-dihydroxycinnamate is an EGF receptor-associated tyrosine kinases inhibitor.
-
DescriptionMethyl 2,5-dihydroxycinnamate is an EGF receptor-associated tyrosine kinases inhibitor.
-
Synonyms——
-
PathwayAngiogenesis
-
TargetEGFR
-
RecptorApoptosis;BiP
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number63177-57-1
-
Formula Weight194.2
-
Molecular FormulaC10H10O4
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCOC(=O)\C=C\c1cc(O)ccc1O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Oida Y, et al. Induction of BiP, an ER-resident protein, prevents the neuronal death induced by transient forebrain ischemia in gerbil. Brain Res. 2008 May 7;1208:217-24.
molnova catalog
related products
-
Desmethyl Erlotinib
OSI-420 is the active metabolite of Erlotinib (EGFR inhibitor with IC50 of 2 nM).
-
Almonertinib mesylat...
Almonertinib mesylate is an irreversible inhibitor of EGFR tyrosine kinase with high selectivity for EGFR-sensitizing and T790M resistance mutations. Almonertinib mesylate can be used in the non-small cell lung cancer studies.
-
Mutated EGFR-IN-1
Mutated EGFR-IN-1 is a useful intermediate for the inhibitors design for mutated EGFR, such as L858R EGFR, Exonl9 deletion activating mutant, and T790M resistance mutant.
